Report Cover

United States TNF Inhibitors Market Report 2017


In this report, the United States TNF Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of TNF Inhibitors in these regions, from 2012 to 2022 (forecast).

United States TNF Inhibitors market competition by top manufacturers/players, with TNF Inhibitors sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Novartis
    Boehringer Ingelheim
    Amgen
    BioPharma
    Mochida Pharmaceutical
    Hanall
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Monotherapy
    Combination Therapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Skin Disease
    Ankylosing Spondylitis
    Gastrointestinal Disease
    Rheumatoid Arthritis
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents

United States TNF Inhibitors Market Report 2017
1 TNF Inhibitors Overview
    1.1 Product Overview and Scope of TNF Inhibitors
    1.2 Classification of TNF Inhibitors by Product Category
        1.2.1 United States TNF Inhibitors Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States TNF Inhibitors Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Monotherapy
        1.2.4 Combination Therapy
    1.3 United States TNF Inhibitors Market by Application/End Users
        1.3.1 United States TNF Inhibitors Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Skin Disease
        1.3.3 Ankylosing Spondylitis
        1.3.4 Gastrointestinal Disease
        1.3.5 Rheumatoid Arthritis
        1.3.6 Others
    1.4 United States TNF Inhibitors Market by Region
        1.4.1 United States TNF Inhibitors Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West TNF Inhibitors Status and Prospect (2012-2022)
        1.4.3 Southwest TNF Inhibitors Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic TNF Inhibitors Status and Prospect (2012-2022)
        1.4.5 New England TNF Inhibitors Status and Prospect (2012-2022)
        1.4.6 The South TNF Inhibitors Status and Prospect (2012-2022)
        1.4.7 The Midwest TNF Inhibitors Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of TNF Inhibitors (2012-2022)
        1.5.1 United States TNF Inhibitors Sales and Growth Rate (2012-2022)
        1.5.2 United States TNF Inhibitors Revenue and Growth Rate (2012-2022)

2 United States TNF Inhibitors Market Competition by Players/Suppliers
    2.1 United States TNF Inhibitors Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States TNF Inhibitors Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States TNF Inhibitors Average Price by Players/Suppliers (2012-2017)
    2.4 United States TNF Inhibitors Market Competitive Situation and Trends
        2.4.1 United States TNF Inhibitors Market Concentration Rate
        2.4.2 United States TNF Inhibitors Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers TNF Inhibitors Manufacturing Base Distribution, Sales Area, Product Type

3 United States TNF Inhibitors Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States TNF Inhibitors Sales and Market Share by Region (2012-2017)
    3.2 United States TNF Inhibitors Revenue and Market Share by Region (2012-2017)
    3.3 United States TNF Inhibitors Price by Region (2012-2017)

4 United States TNF Inhibitors Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States TNF Inhibitors Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States TNF Inhibitors Revenue and Market Share by Type (2012-2017)
    4.3 United States TNF Inhibitors Price by Type (2012-2017)
    4.4 United States TNF Inhibitors Sales Growth Rate by Type (2012-2017)

5 United States TNF Inhibitors Sales (Volume) by Application (2012-2017)
    5.1 United States TNF Inhibitors Sales and Market Share by Application (2012-2017)
    5.2 United States TNF Inhibitors Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States TNF Inhibitors Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 TNF Inhibitors Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer TNF Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Novartis
        6.2.2 TNF Inhibitors Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novartis TNF Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Boehringer Ingelheim
        6.3.2 TNF Inhibitors Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Boehringer Ingelheim TNF Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Amgen
        6.4.2 TNF Inhibitors Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Amgen TNF Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 BioPharma
        6.5.2 TNF Inhibitors Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 BioPharma TNF Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Mochida Pharmaceutical
        6.6.2 TNF Inhibitors Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Mochida Pharmaceutical TNF Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Hanall
        6.7.2 TNF Inhibitors Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Hanall TNF Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 TNF Inhibitors Manufacturing Cost Analysis
    7.1 TNF Inhibitors Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of TNF Inhibitors

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 TNF Inhibitors Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of TNF Inhibitors Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States TNF Inhibitors Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States TNF Inhibitors Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States TNF Inhibitors Sales Volume Forecast by Type (2017-2022)
    11.3 United States TNF Inhibitors Sales Volume Forecast by Application (2017-2022)
    11.4 United States TNF Inhibitors Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures Figure Product Picture of TNF Inhibitors Figure United States TNF Inhibitors Market Size (MT) by Type (2012-2022) Figure United States TNF Inhibitors Sales Volume Market Share by Type (Product Category) in 2016 Figure Monotherapy Product Picture Figure Combination Therapy Product Picture Figure United States TNF Inhibitors Market Size (MT) by Application (2012-2022) Figure United States Sales Market Share of TNF Inhibitors by Application in 2016 Figure Skin Disease Examples Table Key Downstream Customer in Skin Disease Figure Ankylosing Spondylitis Examples Table Key Downstream Customer in Ankylosing Spondylitis Figure Gastrointestinal Disease Examples Table Key Downstream Customer in Gastrointestinal Disease Figure Rheumatoid Arthritis Examples Table Key Downstream Customer in Rheumatoid Arthritis Figure Others Examples Table Key Downstream Customer in Others Figure United States TNF Inhibitors Market Size (Million USD) by Region (2012-2022) Figure The West TNF Inhibitors Revenue (Million USD) and Growth Rate (2012-2022) Figure Southwest TNF Inhibitors Revenue (Million USD) and Growth Rate (2012-2022) Figure The Middle Atlantic TNF Inhibitors Revenue (Million USD) and Growth Rate (2012-2022) Figure New England TNF Inhibitors Revenue (Million USD) and Growth Rate (2012-2022) Figure The South of US TNF Inhibitors Revenue (Million USD) and Growth Rate (2012-2022) Figure The Midwest TNF Inhibitors Revenue (Million USD) and Growth Rate (2012-2022) Figure United States TNF Inhibitors Sales (MT) and Growth Rate (2012-2022) Figure United States TNF Inhibitors Revenue (Million USD) and Growth Rate (2012-2022) Figure United States TNF Inhibitors Market Major Players Product Sales Volume (MT) (2012-2017) Table United States TNF Inhibitors Sales (MT) of Key Players/Suppliers (2012-2017) Table United States TNF Inhibitors Sales Share by Players/Suppliers (2012-2017) Figure 2016 United States TNF Inhibitors Sales Share by Players/Suppliers Figure 2017 United States TNF Inhibitors Sales Share by Players/Suppliers Figure United States TNF Inhibitors Market Major Players Product Revenue (Million USD) (2012-2017) Table United States TNF Inhibitors Revenue (Million USD) by Players/Suppliers (2012-2017) Table United States TNF Inhibitors Revenue Share by Players/Suppliers (2012-2017) Figure 2016 United States TNF Inhibitors Revenue Share by Players/Suppliers Figure 2017 United States TNF Inhibitors Revenue Share by Players/Suppliers Table United States Market TNF Inhibitors Average Price (USD/Kg) of Key Players/Suppliers (2012-2017) Figure United States Market TNF Inhibitors Average Price (USD/Kg) of Key Players/Suppliers in 2016 Figure United States TNF Inhibitors Market Share of Top 3 Players/Suppliers Figure United States TNF Inhibitors Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers TNF Inhibitors Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers TNF Inhibitors Product Category Table United States TNF Inhibitors Sales (MT) by Region (2012-2017) Table United States TNF Inhibitors Sales Share by Region (2012-2017) Figure United States TNF Inhibitors Sales Share by Region (2012-2017) Figure United States TNF Inhibitors Sales Market Share by Region in 2016 Table United States TNF Inhibitors Revenue (Million USD) and Market Share by Region (2012-2017) Table United States TNF Inhibitors Revenue Share by Region (2012-2017) Figure United States TNF Inhibitors Revenue Market Share by Region (2012-2017) Figure United States TNF Inhibitors Revenue Market Share by Region in 2016 Table United States TNF Inhibitors Price (USD/Kg) by Region (2012-2017) Table United States TNF Inhibitors Sales (MT) by Type (2012-2017) Table United States TNF Inhibitors Sales Share by Type (2012-2017) Figure United States TNF Inhibitors Sales Share by Type (2012-2017) Figure United States TNF Inhibitors Sales Market Share by Type in 2016 Table United States TNF Inhibitors Revenue (Million USD) and Market Share by Type (2012-2017) Table United States TNF Inhibitors Revenue Share by Type (2012-2017) Figure Revenue Market Share of TNF Inhibitors by Type (2012-2017) Figure Revenue Market Share of TNF Inhibitors by Type in 2016 Table United States TNF Inhibitors Price (USD/Kg) by Types (2012-2017) Figure United States TNF Inhibitors Sales Growth Rate by Type (2012-2017) Table United States TNF Inhibitors Sales (MT) by Application (2012-2017) Table United States TNF Inhibitors Sales Market Share by Application (2012-2017) Figure United States TNF Inhibitors Sales Market Share by Application (2012-2017) Figure United States TNF Inhibitors Sales Market Share by Application in 2016 Table United States TNF Inhibitors Sales Growth Rate by Application (2012-2017) Figure United States TNF Inhibitors Sales Growth Rate by Application (2012-2017) Table Pfizer Basic Information List Table Pfizer TNF Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017) Figure Pfizer TNF Inhibitors Sales Growth Rate (2012-2017) Figure Pfizer TNF Inhibitors Sales Market Share in United States (2012-2017) Figure Pfizer TNF Inhibitors Revenue Market Share in United States (2012-2017) Table Novartis Basic Information List Table Novartis TNF Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017) Figure Novartis TNF Inhibitors Sales Growth Rate (2012-2017) Figure Novartis TNF Inhibitors Sales Market Share in United States (2012-2017) Figure Novartis TNF Inhibitors Revenue Market Share in United States (2012-2017) Table Boehringer Ingelheim Basic Information List Table Boehringer Ingelheim TNF Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017) Figure Boehringer Ingelheim TNF Inhibitors Sales Growth Rate (2012-2017) Figure Boehringer Ingelheim TNF Inhibitors Sales Market Share in United States (2012-2017) Figure Boehringer Ingelheim TNF Inhibitors Revenue Market Share in United States (2012-2017) Table Amgen Basic Information List Table Amgen TNF Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017) Figure Amgen TNF Inhibitors Sales Growth Rate (2012-2017) Figure Amgen TNF Inhibitors Sales Market Share in United States (2012-2017) Figure Amgen TNF Inhibitors Revenue Market Share in United States (2012-2017) Table BioPharma Basic Information List Table BioPharma TNF Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017) Figure BioPharma TNF Inhibitors Sales Growth Rate (2012-2017) Figure BioPharma TNF Inhibitors Sales Market Share in United States (2012-2017) Figure BioPharma TNF Inhibitors Revenue Market Share in United States (2012-2017) Table Mochida Pharmaceutical Basic Information List Table Mochida Pharmaceutical TNF Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017) Figure Mochida Pharmaceutical TNF Inhibitors Sales Growth Rate (2012-2017) Figure Mochida Pharmaceutical TNF Inhibitors Sales Market Share in United States (2012-2017) Figure Mochida Pharmaceutical TNF Inhibitors Revenue Market Share in United States (2012-2017) Table Hanall Basic Information List Table Hanall TNF Inhibitors Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017) Figure Hanall TNF Inhibitors Sales Growth Rate (2012-2017) Figure Hanall TNF Inhibitors Sales Market Share in United States (2012-2017) Figure Hanall TNF Inhibitors Revenue Market Share in United States (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of TNF Inhibitors Figure Manufacturing Process Analysis of TNF Inhibitors Figure TNF Inhibitors Industrial Chain Analysis Table Raw Materials Sources of TNF Inhibitors Major Players/Suppliers in 2016 Table Major Buyers of TNF Inhibitors Table Distributors/Traders List Figure United States TNF Inhibitors Sales Volume (MT) and Growth Rate Forecast (2017-2022) Figure United States TNF Inhibitors Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure United States TNF Inhibitors Price (USD/Kg) Trend Forecast (2017-2022) Table United States TNF Inhibitors Sales Volume (MT) Forecast by Type (2017-2022) Figure United States TNF Inhibitors Sales Volume (MT) Forecast by Type (2017-2022) Figure United States TNF Inhibitors Sales Volume (MT) Forecast by Type in 2022 Table United States TNF Inhibitors Sales Volume (MT) Forecast by Application (2017-2022) Figure United States TNF Inhibitors Sales Volume (MT) Forecast by Application (2017-2022) Figure United States TNF Inhibitors Sales Volume (MT) Forecast by Application in 2022 Table United States TNF Inhibitors Sales Volume (MT) Forecast by Region (2017-2022) Table United States TNF Inhibitors Sales Volume Share Forecast by Region (2017-2022) Figure United States TNF Inhibitors Sales Volume Share Forecast by Region (2017-2022) Figure United States TNF Inhibitors Sales Volume Share Forecast by Region in 2022 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Wearable Blood Glucose Monitoring Systems Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Urine Based Glucose Monitoring Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Self Glucose Monitoring Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Remote Patient Monitoring (RPM) System Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Non-wearable Blood Glucose Monitoring Systems Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Publisher: QY Research
Chat with us